{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:06:21Z","timestamp":1786539981160,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.clinbiochem.2015.03.009","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T08:42:03Z","timestamp":1428309723000},"page":"617-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme"],"prefix":"10.1016","volume":"48","author":[{"given":"I.K.","family":"Delattre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Van de Walle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Van Campenhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Neels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Verstraete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wallemacq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinbiochem.2015.03.009_bb0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.clinbiochem.2015.03.009_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"issue":"7","key":"10.1016\/j.clinbiochem.2015.03.009_bb0015","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder","volume":"66","author":"Suppes","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.clinbiochem.2015.03.009_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials","volume":"161","author":"Geddes","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"9712","key":"10.1016\/j.clinbiochem.2015.03.009_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clinbiochem.2015.03.009_bb0030","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","article-title":"Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials","volume":"162","author":"Cipriani","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.03.009_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00023210-200923030-00004","article-title":"Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"issue":"9817","key":"10.1016\/j.clinbiochem.2015.03.009_bb0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2015.03.009_bb0045","series-title":"Handbook of drug monitoring methods: therapeutics and drugs of abuse","first-page":"1","article-title":"Introduction to therapeutic drug monitoring","author":"Dasgupta","year":"2008"},{"issue":"11","key":"10.1016\/j.clinbiochem.2015.03.009_bb0050","first-page":"1954","article-title":"Appropriateness of therapeutic drug monitoring for lithium","volume":"89","author":"Ratanajamit","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.clinbiochem.2015.03.009_bb0055","series-title":"Applied pharmacokinetics and pharmacodynamics: principles of therapeutic drug monitoring","first-page":"798","article-title":"Lithium","author":"Bettinger","year":"2006"},{"issue":"4","key":"10.1016\/j.clinbiochem.2015.03.009_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00023210-200923040-00005","article-title":"Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinbiochem.2015.03.009_bb0065","series-title":"Handbook of drug monitoring methods: therapeutics and drugs of abuse","first-page":"67","article-title":"Analytical techniques for measuring concentrations of therapeutic drugs in biological fluids","author":"Dasgupta","year":"2008"},{"issue":"9","key":"10.1016\/j.clinbiochem.2015.03.009_bb0070","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1515\/CCLM.2004.214","article-title":"Evaluation of a new lithium colorimetric assay performed on the dade behring dimension X-pand system","volume":"42","author":"Gruson","year":"2004","journal-title":"Clin Chem Lab Med"},{"issue":"5\u20136","key":"10.1016\/j.clinbiochem.2015.03.009_bb0075","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cca.2011.11.030","article-title":"Comparison of different approaches to evaluate external quality assessment data","volume":"413","author":"Coucke","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2015.03.009_bb0080","first-page":"43","article-title":"Quality assurance in Belgium","volume":"31","author":"Libeer","year":"1995","journal-title":"Ann Ist Super Sanita"},{"key":"10.1016\/j.clinbiochem.2015.03.009_bb0085","author":"Westgard"},{"key":"10.1016\/j.clinbiochem.2015.03.009_bb0095","author":"Westgard"},{"key":"10.1016\/j.clinbiochem.2015.03.009_bb0105","article-title":"Statistics for laboratory method comparison studies","volume":"28\u201332","author":"Magari","year":"2002","journal-title":"BioPharm"},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.03.009_bb0110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/clinchem\/39.3.424","article-title":"Evaluation of regression procedures for methods comparison studies","volume":"39","author":"Linnet","year":"1993","journal-title":"Clin Chem"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:45:56Z","timestamp":1757864756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0009912015000867"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.03.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}